Literature DB >> 2423317

Tumor stenoses of the upper gastrointestinal tract--therapeutic alternatives to laser therapy.

G Lux, H Groitl, C Ell.   

Abstract

Alternatives to laser treatment of tumor stenoses of upper gastrointestinal tract include dilatation, implantation of bridging tubes, radiation therapy and chemotherapy. Based on the experience of 170 bridging tubes implanted and laser therapy in 70 patients with tumor stenoses (presented elsewhere) "tubes and laser" are compared. Complication rate, applicability in very proximal and distal stenoses are in favour of laser therapy, costs, hospitalisation time, possibility to occlude fistulae and short recurrence time after laser therapy are facts speaking for oesophageal bridging tubes. The question "tubes or laser" has to be answered by "tubes and laser" already.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423317     DOI: 10.1055/s-2007-1018407

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  4 in total

1.  Endoscopic laser palliation for advanced malignant dysphagia.

Authors:  S G Bown; R Hawes; K Matthewson; C P Swain; H Barr; P B Boulos; C G Clark
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

Review 2.  Light at the end of the tunnel? Palliation for oesophageal carcinoma.

Authors:  J Cox; J R Bennett
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

3.  Randomized comparison of endoscopic palliation of malignant esophageal stenoses.

Authors:  K H Fuchs; S M Freys; H Schaube; A K Eckstein; A Selch; H Hamelmann
Journal:  Surg Endosc       Date:  1991       Impact factor: 4.584

4.  Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria.

Authors:  Nicola Longo; David Dimmock; Harvey Levy; Krista Viau; Heather Bausell; Deborah A Bilder; Barbara Burton; Christel Gross; Hope Northrup; Fran Rohr; Stephanie Sacharow; Amarilis Sanchez-Valle; Mary Stuy; Janet Thomas; Jerry Vockley; Roberto Zori; Cary O Harding
Journal:  Genet Med       Date:  2018-12-14       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.